NDC 68071-1701

Novolin R

Human Insulin

Novolin R is a Subcutaneous Injection, Solution in the Human Otc Drug category. It is labeled and distributed by Nucare Pharmaceuticals,inc.. The primary component is Insulin Human.

• Product ID: 68071-1701_8150d3e5-d40e-1ce6-e053-2991aa0ab36f
• NDC: 68071-1701
• Product Type: Human Otc Drug
• Proprietary Name: Novolin R
• Generic Name: Human Insulin
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 1991-06-25
• Marketing Category: NDA / NDA
• Application Number: NDA019938
• Labeler Name: NuCare Pharmaceuticals,Inc.
• Substance Name: INSULIN HUMAN
• Active Ingredient Strength: 100 [iU]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 68071-1701-1

10 mL in 1 BOX (68071-1701-1)

• Marketing Start Date: 2019-02-07
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68071-1701-1 [68071170101]

Novolin R INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA019938
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2019-02-07

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN HUMAN	100 [iU]/mL

OpenFDA Data

• SPL SET ID: 8150d3e5-d40d-1ce6-e053-2991aa0ab36f
• Manufacturer:
  • NuCare Pharmaceuticals,Inc.
• UNII:
  • 1Y17CTI5SR
• RxNorm Concept Unique ID - RxCUI:
  • 311033
  • 311034
• UPC Code:
  • 0368071170115

NDC Crossover Matching brand name "Novolin R" or generic name "Human Insulin"

NDC	Brand Name	Generic Name
0169-1833	Novolin	Human Insulin
0169-1834	Novolin	Human Insulin
0169-1837	Novolin	Human Insulin
0169-3003	Novolin	Human Insulin
0169-3004	Novolin	Human Insulin
0169-3007	Novolin	Human Insulin
50090-0403	Novolin	Human Insulin
50090-0497	Novolin	Human Insulin
50090-0498	Novolin	Human Insulin
64725-1833	Novolin	Human Insulin
64725-1834	Novolin	Human Insulin
64725-1837	Novolin	Human Insulin
68071-1701	Novolin	Human Insulin